Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Palovarotene

EU orphan designation number: EU/3/14/1368   
Active ingredient: Palovarotene
Indication: Treatment of fibrodysplasia ossificans progressiva
Sponsor: Medpace Germany GmbH
Theresienhoehe 30, 80339 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/145/14 (2014)8863 of 19/11/2014